Clinical Trial Update: Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients

View source ↗

Summary

A completed clinical trial evaluating posaconazole prophylaxis to prevent COVID-19-associated pulmonary aspergillosis (CAPA) in critically ill patients. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Medical University of Graz | Conditions: COVID-19 Respiratory Infection, Aspergillosis | Status: COMPLETED | Results posted: 2025-02-17